Showing 8,021 - 8,040 results of 100,843 for search '(( 5 mean decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.03s Refine Results
  1. 8021

    CHDs-associated Nkx2.5 mutants displayed aberrant SUMO modification. by Eun Young Kim (132204)

    Published 2013
    “…<p>A. Schematic illustration of Nkx2.5 wild type and seven point mutants selected for sumoylation assays. …”
  2. 8022
  3. 8023
  4. 8024

    Optimal conditions for vigor indexes A and B. by Ahad Asghari (20615202)

    Published 2025
    “…The results revealed that increasing PAW levels up to 0.18 min/mL led to an increase in seed germination percentage, seedling weight (both fresh and dry), seedling length, vigor indexes A and B, and water uptake and decreasing mean germination time. …”
  5. 8025
  6. 8026
  7. 8027
  8. 8028
  9. 8029
  10. 8030
  11. 8031

    Schematic diagram of specimens [5]. by Yihan Tu (22258445)

    Published 2025
    “…The model shows good agreement with experimental data with average deviation within 9.5% and can serve as a simplified yet reliable input for structural design, safety assessment, and advanced finite element modeling of welded steel members.…”
  12. 8032

    Geometrical parameters of specimens [5]. by Yihan Tu (22258445)

    Published 2025
    “…The model shows good agreement with experimental data with average deviation within 9.5% and can serve as a simplified yet reliable input for structural design, safety assessment, and advanced finite element modeling of welded steel members.…”
  13. 8033

    Gene expression profile of <i>Pcgf5</i>-deficient HSPCs. by Sha Si (2635147)

    Published 2016
    “…(D) Venn diagram showing the overlap between genes (listed in gene symbol) up-regulated in LSK cells from <i>Pcgf5</i><sup><i>Δ/Δ</i></sup>, <i>Ezh2</i><sup><i>Δ/Δ</i></sup> [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0154561#pone.0154561.ref018" target="_blank">18</a>], and <i>Bmi1</i> KO [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0154561#pone.0154561.ref019" target="_blank">19</a>] mice (≥2.0-fold compared with the WT control, respectively). …”
  14. 8034
  15. 8035
  16. 8036
  17. 8037
  18. 8038
  19. 8039

    Data_Sheet_1_A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.PDF by Sofia Sandgren (17017017)

    Published 2023
    “…</p>Results<p>While the mean annualized relapse rate was significantly reduced from baseline at each year of follow-up, disability was essentially maintained at a median EDSS of 1.5 and IQR between 1.13 and 2.25. …”
  20. 8040